+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 47 Pages
  • July 2026
  • GlobalData
  • ID: 1945542
First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

First Pacific Co Ltd (First Pacific) is an investment management and holding company with major interests in consumer food products, infrastructure, natural resources, and telecommunications. The company offers consumer branded products such as dairy, snack foods, noodles, food seasonings, foods, and beverages, nutrition and special. It is also involved in the distribution and supply of electricity, operation of toll roads, hospital groups, and water distribution. First Pacific markets its products under the Indomilk, Tiga Sapi, Milkuat, Kremer, Cap Enaak and Indoeskrim brand names. The company has presence across Singapore, Indonesia, and Philippines. First Pacific is headquartered in Hong Kong.

First Pacific Co Ltd Key Recent Developments

  • May 14, 2026: PLDT Reports 3% Rise in Gross Service Revenues to ?54.9 B in Q1 2026
  • May 04, 2026: Philex Mining Reports Q1 2026 Financial Results as Silangan Project Enters Process Plant Commissioning
  • Mar 30, 2026: First Pacific Announces 2025 Full-Year Audited Results
  • Nov 11, 2025: PLDT Reports 3% Growth in Consolidated Gross Service Revenues to ?158.9 Billion in First Nine Months of 2025

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • CK Life Sciences Int'l (Holdings) Inc - Key Facts
  • CK Life Sciences Int'l (Holdings) Inc - Key Employees
  • CK Life Sciences Int'l (Holdings) Inc - Key Employee Biographies
  • CK Life Sciences Int'l (Holdings) Inc - Major Products and Services
  • CK Life Sciences Int'l (Holdings) Inc - History
  • CK Life Sciences Int'l (Holdings) Inc - Company Statement
  • CK Life Sciences Int'l (Holdings) Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • CK Life Sciences Int'l (Holdings) Inc - Business Description
  • Business Segment: Agriculture-Related
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Nutraceutical
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Pharmaceuticals & Diagnostics R&D
  • Overview
  • Performance
  • Business Segment: Unallocated
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: North America
  • Performance
  • R&D Overview
  • CK Life Sciences Int'l (Holdings) Inc - Corporate Strategy
  • CK Life Sciences Int'l (Holdings) Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • CK Life Sciences Int'l (Holdings) Inc - Strengths
  • CK Life Sciences Int'l (Holdings) Inc - Weaknesses
  • CK Life Sciences Int'l (Holdings) Inc - Opportunities
  • CK Life Sciences Int'l (Holdings) Inc - Threats
  • CK Life Sciences Int'l (Holdings) Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • CK Life Sciences Int'l (Holdings) Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 18, 2026: CK Life Sciences Sequencio Therapeutics Appoints Emily Tan as Chief Operating Officer
  • Mar 31, 2026: CK Life Sciences’ Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting
  • Mar 10, 2026: CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development
  • Aug 12, 2025: CK Life Sciences : 2025 First Half Results - An Increase in R&D Investments
  • Apr 22, 2025: CK Life Sciences Investigational Cancer Vaccines Deliver Promising Results - New Preclinical Study Data to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting
  • Apr 22, 2025: Business Update on Preclinical Studies of Cancer Vaccines And the Progress of Research Collaboration to Develop An AI-Empowered Cancer Vaccine Platform
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • CK Life Sciences Int'l (Holdings) Inc, Key Facts
  • CK Life Sciences Int'l (Holdings) Inc, Key Employees
  • CK Life Sciences Int'l (Holdings) Inc, Key Employee Biographies
  • CK Life Sciences Int'l (Holdings) Inc, Major Products and Services
  • CK Life Sciences Int'l (Holdings) Inc, History
  • CK Life Sciences Int'l (Holdings) Inc, Subsidiaries
  • CK Life Sciences Int'l (Holdings) Inc, Key Competitors
  • CK Life Sciences Int'l (Holdings) Inc, Ratios based on current share price
  • CK Life Sciences Int'l (Holdings) Inc, Annual Ratios
  • CK Life Sciences Int'l (Holdings) Inc, Interim Ratios
  • CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • CK Life Sciences Int'l (Holdings) Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • CK Life Sciences Int'l (Holdings) Inc, Performance Chart (2021 - 2025)
  • CK Life Sciences Int'l (Holdings) Inc, Ratio Charts
  • CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • CK Life Sciences Int'l (Holdings) Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026